Organization · Venture Capital
Bay City Capital LLC
Bay City Capital LLC is a life sciences investment firm based in the San Francisco Bay Area, managing five venture capital funds with a total of $1.3 billion in capital commitments. The firm invests in a diverse range of life sciences sectors, including biopharmaceuticals and medical devices.
Overview
What Bay City Capital LLC does
What Bay City Capital LLC is
Bay City Capital LLC is a life sciences investment firm based in the San Francisco Bay Area, managing five venture capital funds with a total of $1.3 billion in capital commitments. The firm invests in a diverse range of life sciences sectors, including biopharmaceuticals and medical devices.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 1997
- Approximate age
- About 29 years
- Structured capabilities
- Funder
- Last reviewed
- March 18, 2026
Official channels
Find Bay City Capital LLC elsewhere
Open the official website or a supported primary organization account.
Capability profile
Bay City Capital LLC as a funder
Investment thesis
Bay City Capital LLC is dedicated to investing in innovative life sciences companies, emphasizing growth and restructuring opportunities across various sectors.
Focus narrative
Bay City Capital focuses on investing in life sciences companies across a range of sectors, including biopharmaceuticals, medical devices, diagnostics, healthcare IT, nutrition, and agribusiness. The firm invests at various stages, from seed stage to public companies, and emphasizes innovation, restructuring opportunities, and growth investing.
Value beyond capital
Bay City Capital provides strategic guidance and support to its portfolio companies, leveraging its extensive industry expertise and network to drive innovation and growth.
Focus and fit
- Stages
- Seed · Series A · Series B · Growth Equity · Ipo
- Sectors
- Biotech · Healthcare · Medical Devices · Health Platforms · Diagnostics · Pharma Tech
- Regions
- Global
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 100
- Recorded notable exits
- Nevro, Dermira, and Map Pharmaceuticals
Portfolio context
Bay City Capital has a diverse portfolio of over 100 companies, including notable names such as Oculis, Gritstone Oncology, Imara, Kezar Life Sciences, NextCure, Synchronicity Pharma, Nevro (Past IPO), Dermira (Past IPO), and Map Pharmaceuticals (Acquired by Allergan).
Common questions
What to know about Bay City Capital LLC
Upseed classifies Bay City Capital LLC under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 18, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.